Zimmer Biomet HoldingsXSWX:ZBH +0.68%69 Gross Margin % is 72.39% as of Mar. 2026, which is 1% above its 10-year median of 71.33. GuruFocus rates XSWX:ZBH with a GF Score™ of 69/100 and a GF Value™ of CHF100.92 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Zimmer Biomet Holdings ranks better than 79.75% on this metric.
XSWX:ZBH's Gross Margin % is ranked better than 79.75% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs XSWX:ZBH: 70.03
Zimmer Biomet Holdings had a gross margin of 72.39% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Zimmer Biomet Holdings was -0.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zimmer Biomet Holdings had a gross margin of 72.39% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Zimmer Biomet Holdings Gross Margin % Related Terms
Zimmer Biomet Holdings Gross Margin % Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ZBH vs PEN, GMED, STE: Gross Margin % Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zimmer Biomet Holdings (XSWX:ZBH) has a Gross Margin % of 72.39% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Zimmer Biomet Holdings and its competitors. This is near median its historical median of 71.33. Over the past decade, Zimmer Biomet Holdings' Gross Margin % has ranged from 68.94 to 72.67. According to the industry distribution chart, Zimmer Biomet Holdings ranks #163 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 20.2%.
Is Zimmer Biomet Holdings' Gross Margin % too high?
Zimmer Biomet Holdings' current Gross Margin % of 72.39% is near median its 10-year median of 71.33. Over the past 10 years, this metric has ranged from a low of 68.94 to a high of 72.67. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Zimmer Biomet Holdings' value of 72.39% is 39% above this industry median. Based on the distribution chart, Zimmer Biomet Holdings ranks #163 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zimmer Biomet Holdings has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Gross Margin % compare to PEN and GMED?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #163 out of 805 companies for Gross Margin %. This places Zimmer Biomet Holdings in the top 20% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Zimmer Biomet Holdings' value of 72.39% is 39% above this benchmark. Historically, Zimmer Biomet Holdings' own Gross Margin % has ranged from 68.94 to 72.67 over the past decade. While the company's 10-year median is 71.33 vs. the industry median of 52.07, Zimmer Biomet Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zimmer Biomet Holdings's current Gross Margin % of 72.39% is 39% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Zimmer Biomet Holdings and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current Gross Margin % is 72.39%, which is near median its own 10-year median of 71.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF100.92, compared to a current price of CHF74.50 — trading 26.2% below its estimated fair value. The current Gross Margin % is 72.39%, which is near median its 10-year median of 71.33 and 39% above the Medical Devices & Instruments industry median of 52.07. Zimmer Biomet Holdings' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Gross Margin % is 72.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF74.50 is trading 26.2% below its estimated GF Value™ of CHF100.92.
GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.
Key valuation signals for XSWX:ZBH:
Gross Margin %: 72.39% (near median its 10-year median of 71.33)
GF Value™: CHF100.92 vs. price of CHF74.50 (26.2% below fair value)
Industry Position: 39% above the Medical Devices & Instruments median (#163 of 805)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
69GF Score
Get the complete analysis for XSWX:ZBH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
